{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:45:23Z","timestamp":1792201523054,"version":"4.4.0"},"reference-count":79,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"D34 Health-Digital Driven Diagnostics, prognostics and therapeutics for sustainable Health care","doi-asserted-by":"publisher","award":["PNC0000001"],"award-info":[{"award-number":["PNC0000001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"D34 Health-Digital Driven Diagnostics, prognostics and therapeutics for sustainable Health care","doi-asserted-by":"publisher","award":["B53C22006090001"],"award-info":[{"award-number":["B53C22006090001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"D34 Health-Digital Driven Diagnostics, prognostics and therapeutics for sustainable Health care","doi-asserted-by":"publisher","award":["300390PNC22CAMPIGLIA"],"award-info":[{"award-number":["300390PNC22CAMPIGLIA"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Cancer, a leading cause of premature death, arises from genetic and epigenetic mutations that transform normal cells into tumor cells, enabling them to proliferate, evade cell death, and stimulate angiogenesis. Recent evidence indicates that chemokines are essential in tumor development, activating receptors that promote proliferation, invasion, and metastasis. The CXCR4\/CXCL12 signaling pathway is gaining attention as a promising target for cancer therapy. CXCR4, a chemokine receptor, is often overexpressed in various types of cancer, including kidney, lung, brain, prostate, breast, pancreas, ovarian, and melanomas. When it binds to its endogenous ligand, CXCL12, it promotes cell survival, proliferation, and migration, crucial mechanisms for the retention of hematopoietic stem cells in the bone marrow and the movement of lymphocytes. The extensive expression of CXCR4 in cancer, coupled with the constant presence of CXCL12 in various organs, drives the activation of this axis, which in turn facilitates angiogenesis, tumor progression, and metastasis. Given the detrimental role of the CXCR4\/CXCL12 axis, the search for drugs acting selectively against this protein represents an open challenge. This review aims to summarize the recent advancements in the design and development of CXCR4 antagonists as potential anticancer agents.<\/jats:p>","DOI":"10.3390\/molecules30061380","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T05:03:59Z","timestamp":1742447039000},"page":"1380","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Targeting the CXCR4\/CXCL12 Axis in Cancer Therapy: Analysis of Recent Advances in the Development of Potential Anticancer Agents"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-9717","authenticated-orcid":false,"given":"Gerardina","family":"Smaldone","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-6472","authenticated-orcid":false,"given":"Francesca","family":"Di Matteo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Castelluccio","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2328-2824","authenticated-orcid":false,"given":"Valeria","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8296-1888","authenticated-orcid":false,"given":"Maria Rosaria","family":"Miranda","sequence":"additional","affiliation":[{"name":"PhD Program in Drug Discovery and Development, University of Salerno, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-972X","authenticated-orcid":false,"given":"Michele","family":"Manfra","sequence":"additional","affiliation":[{"name":"Department of Health Science, University of Basilicata, Viale dell\u2019Ateneo Lucano 10, 85100 Potenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-2181","authenticated-orcid":false,"given":"Pietro","family":"Campiglia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-5526","authenticated-orcid":false,"given":"Vincenzo","family":"Vestuto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Salerno, Via G. Paolo II, 84084 Fisciano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: Global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bouyahya, A., Mechchate, H., Oumeslakht, L., Zeouk, I., Aboulaghras, S., Balahbib, A., Zengin, G., Kamal, M.A., Gallo, M., and Montesano, D. (2022). The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. Biomolecules, 12.","DOI":"10.3390\/biom12030367"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: Positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Shi, Y., Riese, D.J., and Shen, J. (2020). The Role of the CXCL12\/CXCR4\/CXCR7 Chemokine Axis in Cancer. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.574667"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biocel.2017.12.018","article-title":"The good and bad faces of the CXCR4 chemokine receptor","volume":"95","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/ard.2008.098277","article-title":"Association between a stromal cell-derived factor 1 (SDF-1\/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis","volume":"68","author":"Manetti","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.gene.2006.02.001","article-title":"Identification and expression of novel isoforms of human stromal cell-derived factor 1","volume":"374","author":"Yu","year":"2006","journal-title":"Gene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1012808525370","article-title":"Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction","volume":"25","author":"Pillarisetti","year":"2001","journal-title":"Inflammation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 Axis in Cancer: From Mechanisms to Clinical Applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/onc.2015.139","article-title":"CXCL12\/CXCR4: A symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks","volume":"35","author":"Guo","year":"2016","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pawig, L., Klasen, C., Weber, C., Bernhagen, J., and Noels, H. (2015). Diversity and Inter-Connections in the CXCR4 Chemokine Receptor\/Ligand Family: Molecular Perspectives. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00429"},{"key":"ref_14","unstructured":"(2025, January 10). RCSB PDB. Available online: https:\/\/www.wwpdb.org\/pdb?id=pdb_00003odu."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Naumann, U., Cameroni, E., Pruenster, M., Mahabaleshwar, H., Raz, E., Zerwes, H.G., Rot, A., and Thelen, M. (2010). CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009175"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1182\/blood-2008-12-196618","article-title":"CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling","volume":"113","author":"Levoye","year":"2009","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hadad, I., Veithen, A., Springael, J.Y., Sotiropoulou, P.A., Mendes Da Costa, A., Miot, F., Naeije, R., De Deken, X., and Entee, K.M. (2013). Stroma cell-derived factor-1\u03b1 signaling enhances calcium transients and beating frequency in rat neonatal cardiomyocytes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056007"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","article-title":"The intricate role of CXCR4 in cancer","volume":"124","author":"Chatterjee","year":"2014","journal-title":"Adv. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1074\/jbc.273.4.1839","article-title":"The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades","volume":"273","author":"Gutkind","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.4049\/jimmunol.169.10.5546","article-title":"G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways","volume":"169","author":"Vlahakis","year":"2002","journal-title":"J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1096\/fasebj.13.13.1699","article-title":"The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK\/STAT pathway","volume":"13","author":"Mellado","year":"1999","journal-title":"FASEB J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbamem.2006.11.002","article-title":"Regulation of CXCR4 signaling","volume":"1768","author":"Busillo","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ncb3096","article-title":"Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration","volume":"17","author":"Rafii","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bianchi, M.E., and Mezzapelle, R. (2020). The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.02109"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/acn3.50926","article-title":"A CXCR4 receptor agonist strongly stimulates axonal regeneration after damage","volume":"6","author":"Zanetti","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/glia.21080","article-title":"Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells","volume":"59","author":"Li","year":"2011","journal-title":"Glia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1096\/fj.03-0935fje","article-title":"Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis","volume":"18","author":"Pikarsky","year":"2004","journal-title":"FASEB J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/labinvest.3700482","article-title":"Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: Implications for angiogenesis and glioma cell invasion","volume":"86","author":"Zagzag","year":"2006","journal-title":"Lab. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1002\/jcb.28253","article-title":"CXCL12\/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K\/AKT signal pathway","volume":"120","author":"Yin","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3892\/or.2014.3536","article-title":"Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer","volume":"32","author":"Liu","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1158\/0008-5472.CAN-17-0454","article-title":"CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a\/16-1-Mediated ERK and BCL2\/Cyclin D1 Pathways","volume":"78","author":"Klein","year":"2018","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.2007.143941","article-title":"The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia","volume":"57","author":"Thomas","year":"2008","journal-title":"Gut"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1440-1827.2010.02548.x","article-title":"CXCR4 and cancer","volume":"60","author":"Furusato","year":"2010","journal-title":"Pathol. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2007.05.182","article-title":"CXCR4\/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signalling pathway","volume":"359","author":"Liang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/carcin\/bgn228","article-title":"Stromal cell-derived factor-1\u03b1 (SDF-1\u03b1\/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1\/2-NFkB\/interleukin-6 pathway","volume":"30","author":"Chu","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Novi, S., Vestuto, V., Campiglia, P., Tecce, N., Bertamino, A., and Tecce, M.F. (2023). Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation. Nutrients, 15.","DOI":"10.20944\/preprints202305.1263.v1"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1158\/0008-5472.CAN-05-1293","article-title":"Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: Role of MEK\/ERK signaling pathway-dependent NF-kappaB activation","volume":"65","author":"Kukreja","year":"2005","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1038\/sj.onc.1208621","article-title":"CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells","volume":"24","author":"Hartmann","year":"2005","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2012.02.035","article-title":"SDF-1\/CXCR4 signalling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway","volume":"322","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12032-014-0377-x","article-title":"SDF-1\/CXCR4 signalling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K\/AKT pathway","volume":"32","author":"Yang","year":"2015","journal-title":"Med. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Liao, A., Shi, R., Jiang, Y., Tian, S., Li, P., Song, F., Qu, Y., Li, J., Yun, H., and Yang, X. (2017). SDF-1\/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma. Mol. Neurobiol., 54.","DOI":"10.1007\/s12035-017-0508-4"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-014-2020-8","article-title":"The SDF-1\/CXCR4 axis induces epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"392","author":"Li","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.canlet.2014.08.012","article-title":"SDF-1\/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt\/\u03b2-catenin signalling pathway","volume":"354","author":"Hu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/path.1876","article-title":"Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes","volume":"208","author":"Valle","year":"2006","journal-title":"J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.leu.2404357","article-title":"The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis","volume":"20","author":"Ratajczak","year":"2006","journal-title":"Leukemia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.copbio.2016.02.007","article-title":"Impact of the physical microenvironment on tumor progression and metastasis","volume":"40","author":"Spill","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.18632\/oncotarget.2207","article-title":"Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4\/CXCL12 axis and promote their polarization toward the M2 phenotype","volume":"5","author":"Beider","year":"2014","journal-title":"Oncotarget"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1074\/jbc.M309546200","article-title":"Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: Transfer of binding site to the CXCR3 receptor","volume":"279","author":"Rosenkilde","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bcp.2006.05.010","article-title":"Characterization of the molecular pharmacology of AMD3100: A specific antagonist of the G-protein coupled chemokine receptor, CXCR4","volume":"72","author":"Fricker","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18632\/oncoscience.311","article-title":"Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 together with lapatinib, metformin and niacinamide","volume":"3","author":"Rios","year":"2016","journal-title":"Oncoscience"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI40283","article-title":"Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice","volume":"120","author":"Kioi","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"E2182-90","DOI":"10.1073\/pnas.1404943111","article-title":"Quantitative phosphoproteomic analysis reveals system-wide signalling pathways downstream of SDF-1\/CXCR4 in breast cancer stem cells","volume":"111","author":"Yi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1541-7786.MCR-10-0235","article-title":"Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1\/2 in prostate cancer cells","volume":"9","author":"Chetram","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.2235846100","article-title":"A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors","volume":"100","author":"Rubin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/jm070679i","article-title":"Discovery of small molecule CXCR4 antagonists","volume":"50","author":"Zhan","year":"2007","journal-title":"J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14756360290024227","article-title":"Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents","volume":"17","author":"Scozzafava","year":"2002","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Liang, Z., Zhan, W., Zhu, A., Yoon, Y., Lin, S., Sasaki, M., Klapproth, J.M., Yang, H., Grossniklaus, H.E., and Xu, J. (2012). Development of a unique small molecule modulator of CXCR4. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034038"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s12253-020-00827-x","article-title":"Novel CXCR4 Inhibitor CPZ1344 Inhibits the Proliferation, Migration and Angiogenesis of Glioblastoma","volume":"26","author":"Luo","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5603\/FHC.a2021.0008","article-title":"Naringenin promotes SDF-1\/CXCR4 signaling pathway in BMSCs osteogenic differentiation","volume":"59","author":"Wang","year":"2021","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2016.11.026","article-title":"Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library","volume":"126","author":"Bai","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"111823","DOI":"10.1016\/j.ejmech.2019.111823","article-title":"Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4\/CXCL12 axis","volume":"185","author":"Wu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejmech.2017.05.030","article-title":"Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study","volume":"136","author":"Bai","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1021\/ml400183q","article-title":"Discovery of tetrahydroisoquinoline-based CXCR4 antagonists","volume":"4","author":"Truax","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/bjc.2013.124","article-title":"Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070","volume":"108","author":"Swidenbank","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1016\/j.bmcl.2008.05.092","article-title":"Identification of novel non-peptide CXCR4 antagonists by ligand-based design approach","volume":"18","author":"Ueda","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1111\/bph.12842","article-title":"Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis","volume":"171","author":"Thiele","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejmech.2019.01.066","article-title":"Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approach","volume":"1","author":"Ostacolo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"116128","DOI":"10.1016\/j.ejmech.2024.116128","article-title":"Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization","volume":"266","author":"Ciaglia","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1021\/jm801065q","article-title":"Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo","volume":"51","author":"Thoma","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Van Hout, A., D\u2019huys, T., Oeyen, M., Schols, D., and Van Loy, T. (2017). Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176057"},{"key":"ref_76","first-page":"141","article-title":"Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model","volume":"9","author":"Tulotta","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1021\/cb400521b","article-title":"Minimalist hybrid ligand\/receptor-based pharmacophore model for CXCR4 applied to a small-library of marine natural products led to the identification of phidianidine a as a new CXCR4 ligand exhibiting antagonist activity","volume":"8","author":"Vitale","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/ol200234r","article-title":"Structure and cytotoxicity of phidianidines A and B: First finding of 1,2,4-oxadiazole system in a marine natural product","volume":"13","author":"Carbone","year":"2011","journal-title":"Org. Lett."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Vitale, R.M., Thellung, S., Tinto, F., Solari, A., Gatti, M., Nuzzo, G., Ioannou, E., Roussis, V., Ciavatta, M.L., and Manzo, E. (2020). Identification of the hydantoin alkaloids parazoanthines as novel CXCR4 antagonists by computational and in vitro functional characterization. Bioorg. Chem., 105.","DOI":"10.1016\/j.bioorg.2020.104337"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/6\/1380\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:56:54Z","timestamp":1760029014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/6\/1380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":79,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["molecules30061380"],"URL":"https:\/\/doi.org\/10.3390\/molecules30061380","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}